Marlabs Recognized as a Product Challenger in the ISG Provider Lens™ for Specialty Analytics Services in Life Sciences and Healthcare 2025

Share this content:

Marlabs Team

+ Connect on Linkedin
Our team is committed to getting you the resources you need to make you the hero in your organization.
Related Services:

New York/Bengaluru, India – [October 7, 2025] - Marlabs LLC, a global digital solutions provider specializing in data, analytics, AI, and enterprise transformation solutions, has been recognized as a “Product Challenger” in the 2025 ISG Provider Lens™ report for Specialty Analytics Services - Life Sciences and Healthcare. This recognition highlights Marlabs’ expertise in engineering advanced data and AI solutions tailored to solve the complex challenges across the life sciences and healthcare value chain.

This ISG report benchmarked some of the world's top AI and analytics providers with the capability to deliver solutions through a rigorous, evidence-based approach for life sciences and healthcare enterprises. Specifically, the assessment focused on how they apply powerful technologies like computer vision, NLP, and GenAI to solve critical business challenges.

"AI and analytics are fundamentally reshaping critical functions across life sciences and healthcare, be it accelerating clinical development, personalizing patient care, or streamlining commercial operations. To capitalize on these opportunities, data maturity and contextual deployment of technologies is non-negotiable. Marlabs is at the forefront of this shift, helping businesses adopt and scale enterprise AI-powered intelligence that enables them to maximize the value of their data and deliver better outcomes faster and more efficiently."
-Rao Kunche, Senior Vice President of Healthcare & Life Sciences at Marlabs.

The life sciences and healthcare industry is at a critical inflection point where the sheer volume of complex data is both a challenge and opportunity. To help businesses navigate this juncture, Marlabs is enabling them to move beyond conventional analytics to AI-driven intelligence that accelerates enterprise decision-making and processes at scale.

At the heart of this approach lies Marlabs’ continuous investment in next-gen AI and analytics capabilities that cater to evolving industry needs, combined with their deep domain expertise. Partnering with their clients, Marlabs delivers purpose-built solutions that address critical challenges — from streamlining the path to drug commercialization for life sciences firms to optimizing care delivery and personalizing patient journeys for payers and providers. With the focused application of technologies, Marlabs is dedicated to empowering organizations to not only accelerate their digital transformations but to drive new models of research, treatment, and operational excellence.

“In life sciences and healthcare, the critical challenge for businesses is driving high-trust, high-speed pathways from data to decisive action. At Marlabs, we are constantly innovating to bridge that gap. By building and implementing bespoke data and AI solutions, we empower our clients to streamline their workflows and make decisions with intelligence, enabling them to drive faster and improved clinical and financial outcomes with greater operational efficiency," said Scott Morgan, Executive Vice President of Data and AI at Marlabs.

About Marlabs:
Marlabs designs and develops digital solutions with data at the center. We leverage our deep data expertise and cutting-edge technology to empower businesses with actionable insights and achieve improved digital outcomes.

Marlabs’ data-first approach intersects with AI, analytics, digital product engineering, and advisory services to build and scale digital solutions. We work with leading companies around the world to make operations sleeker, keep customers closer, transform data into decisions, boost legacy system performance, and seize novel opportunities in new digital revenue streams.

Marlabs is headquartered in New Jersey, with offices in the US, Germany, Canada, Brazil, Bulgaria, and India.

www.marlabs.com